688253 英诺特
已收盘 09-19 15:00:01
资讯
新帖
简况
英诺特（688253）披露2025年半年度持续督导跟踪报告，9月17日股价上涨0.69%
证券之星 · 09-17
英诺特（688253）披露2025年半年度持续督导跟踪报告，9月17日股价上涨0.69%
英诺特：选举陈廷友先生为公司第二届董事会职工代表董事
证券日报网 · 09-15
英诺特：选举陈廷友先生为公司第二届董事会职工代表董事
股市必读：英诺特中报 - 第二季度单季净利润同比下降50.51%
证券之星 · 08-31
股市必读：英诺特中报 - 第二季度单季净利润同比下降50.51%
每周股票复盘：英诺特（688253）中报营收降34.35%
证券之星 · 08-30
每周股票复盘：英诺特（688253）中报营收降34.35%
英诺特（688253）2025年中报简析：净利润同比下降39.36%，三费占比上升明显
证券之星 · 08-29
英诺特（688253）2025年中报简析：净利润同比下降39.36%，三费占比上升明显
英诺特2025年1-6月净利润为1.25亿元，较去年同期下滑39.36%
金融界 · 08-28
英诺特2025年1-6月净利润为1.25亿元，较去年同期下滑39.36%
英诺特：上半年净利润1.25亿元，同比下降39.36%
格隆汇 · 08-28
英诺特：上半年净利润1.25亿元，同比下降39.36%
医疗器械行业行业研究：脑机接口行业深度：政策+创新双轮驱动，商业化落地进入快车道
国金证券 · 08-10
医疗器械行业行业研究：脑机接口行业深度：政策+创新双轮驱动，商业化落地进入快车道
个股概念调整|英诺特新增“肝炎概念”概念
市场透视 · 08-05
个股概念调整|英诺特新增“肝炎概念”概念
猴痘概念盘中跳水，义翘神州跌1.06%
市场透视 · 08-04
猴痘概念盘中跳水，义翘神州跌1.06%
英诺特中标乐山市人民医院试剂项目 券商看好买入评级提振市场信心
自选股中标信息 · 07-30
英诺特中标乐山市人民医院试剂项目 券商看好买入评级提振市场信心
每周股票复盘：英诺特（688253）完成7801.24万元股份回购
证券之星 · 07-26
每周股票复盘：英诺特（688253）完成7801.24万元股份回购
英诺特：累计回购约211万股
每日经济新闻 · 07-25
英诺特：累计回购约211万股
每周股票复盘：英诺特（688253）全资子公司获新资质拓宽产品种类
证券之星 · 07-19
每周股票复盘：英诺特（688253）全资子公司获新资质拓宽产品种类
英诺特(688253.SH)子公司近期获得一项资质
智通财经 · 07-18
英诺特(688253.SH)子公司近期获得一项资质
多家跨国医疗巨头奔赴链博会，本土药械供应链再升级
第一财经 · 07-15
多家跨国医疗巨头奔赴链博会，本土药械供应链再升级
每周股票复盘：英诺特（688253）全资子公司获流感病毒抗原检测试剂盒长期资质
证券之星 · 07-12
每周股票复盘：英诺特（688253）全资子公司获流感病毒抗原检测试剂盒长期资质
英诺特：子公司新取得一项产品资质 有助于提高公司市场拓展能力
中国财富通 · 07-07
英诺特：子公司新取得一项产品资质 有助于提高公司市场拓展能力
英诺特最新公告：全资子公司唐山英诺特取得1项美国FDA510（k）产品文号
证券之星 · 07-06
英诺特最新公告：全资子公司唐山英诺特取得1项美国FDA510（k）产品文号
英诺特全资子公司唐山英诺特近期新取得产品资质1项
格隆汇 · 07-06
英诺特全资子公司唐山英诺特近期新取得产品资质1项
加载更多
公司概况
公司名称：
北京英诺特生物技术股份有限公司
所属行业：
医药制造业
上市日期：
2022-07-28
主营业务：
北京英诺特生物技术股份有限公司的主营业务是POCT快速诊断产品研发、生产和销售。公司的主要产品是呼吸道系列、优生优育系列、其他试剂系列、POCT诊断仪器。
发行价格：
26.06
{"stockData":{"symbol":"688253","market":"SH","secType":"STK","nameCN":"英诺特","latestPrice":30.9,"timestamp":1758265201000,"preClose":31.02,"halted":0,"volume":1250487,"delay":0,"changeRate":-0.0039,"floatShares":68810700,"shares":136000000,"eps":1.2141,"marketStatus":"已收盘","change":-0.12,"latestTime":"09-19 15:00:01","open":30.9,"high":31.27,"low":30.6,"amount":38546700,"amplitude":0.0216,"askPrice":30.9,"askSize":68,"bidPrice":30.89,"bidSize":2,"shortable":0,"etf":0,"ttmEps":1.2141,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1758504600000},"marketStatusCode":5,"adr":0,"adjPreClose":31.02,"symbolType":"stock_kcb","openAndCloseTimeList":[[1758245400000,1758252600000],[1758258000000,1758265200000]],"highLimit":34.12,"lowLimit":27.92,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":136458196,"isCdr":false,"pbRate":2.09,"roa":"--","peRate":25.450951,"roe":"5.91%","epsLYR":1.81,"committee":-0.232198,"marketValue":4217000000,"turnoverRate":0.0182,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-09-22。","afterMarket":{"amount":0,"volume":0,"close":30.9,"buyVolume":0,"sellVolume":0,"time":1758267239260,"indexStatus":"已收盘 09-19 15:30:00","preClose":31.02},"floatMarketCap":2126000000},"requestUrl":"/m/hq/s/688253","defaultTab":"news","newsList":[{"id":"2568497448","title":"英诺特（688253）披露2025年半年度持续督导跟踪报告，9月17日股价上涨0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568497448","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568497448?lang=zh_cn&edition=full","pubTime":"2025-09-17 22:56","pubTimestamp":1758120978,"startTime":"0","endTime":"0","summary":"截至2025年9月17日收盘，英诺特报收于30.85元，较前一交易日上涨0.69%，最新总市值为42.1亿元。近日，华泰联合证券有限责任公司发布关于北京英诺特生物技术股份有限公司2025年半年度持续督导跟踪报告。公告显示，华泰联合证券对英诺特2025年上半年持续督导期间，确认公司治理、内部控制及信息披露制度得到有效执行，未发现公司存在重大违法违规或违背承诺事项的情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700040739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"gpt_icon":0},{"id":"2567148336","title":"英诺特：选举陈廷友先生为公司第二届董事会职工代表董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2567148336","media":"证券日报网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567148336?lang=zh_cn&edition=full","pubTime":"2025-09-15 21:39","pubTimestamp":1757943540,"startTime":"0","endTime":"0","summary":"证券日报网讯9月15日晚间，英诺特发布公告称，同意选举陈廷友先生为公司第二届董事会职工代表董事。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-15/doc-infqqytz4305710.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-15/doc-infqqytz4305710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688253"],"gpt_icon":0},{"id":"2564485072","title":"股市必读：英诺特中报 - 第二季度单季净利润同比下降50.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564485072","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564485072?lang=zh_cn&edition=full","pubTime":"2025-09-01 06:47","pubTimestamp":1756680430,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，英诺特报收于31.33元，下跌1.69%，换手率5.99%，成交量4.12万手，成交额1.29亿元。来自业绩披露要点：2025年第二季度单季度归母净利润同比下降50.51%。股本股东变化股东户数变动近日英诺特披露，截至2025年6月30日公司股东户数为7269.0户，较3月31日减少220.0户，减幅为2.94%。关于变更注册资本、取消监事会及修订《公司章程》并办理工商登记的公告北京英诺特生物技术股份有限公司拟变更注册资本，由13,606.0816万元变更为13,645.8196万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090100000914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253"],"gpt_icon":0},{"id":"2563887024","title":"每周股票复盘：英诺特（688253）中报营收降34.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563887024","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563887024?lang=zh_cn&edition=full","pubTime":"2025-08-31 05:44","pubTimestamp":1756590256,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，英诺特报收于31.33元，较上周的32.94元下跌4.89%。本周，英诺特8月26日盘中最高价报33.6元。英诺特当前最新总市值42.75亿元，在医疗器械板块市值排名88/126，在两市A股市值排名3697/5152。本周关注点业绩披露要点：英诺特2025年中报显示，公司主营收入2.76亿元，同比下降34.35%。股本股东变化截至2025年6月30日，英诺特股东户数为7,269户，较3月31日减少220户，减幅2.94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100000931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253"],"gpt_icon":0},{"id":"2563070501","title":"英诺特（688253）2025年中报简析：净利润同比下降39.36%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2563070501","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563070501?lang=zh_cn&edition=full","pubTime":"2025-08-30 06:16","pubTimestamp":1756505793,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期英诺特发布2025年中报。截至本报告期末，公司营业总收入2.76亿元，同比下降34.35%，归母净利润1.25亿元，同比下降39.36%。按单季度数据看，第二季度营业总收入6946.07万元，同比下降50.19%，第二季度归母净利润2978.01万元，同比下降50.51%。本报告期英诺特三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达47.9%。去年的净利率为39.73%，算上全部成本后，公司产品或服务的附加值极高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083000010592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253"],"gpt_icon":0},{"id":"2562105192","title":"英诺特2025年1-6月净利润为1.25亿元，较去年同期下滑39.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562105192","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562105192?lang=zh_cn&edition=full","pubTime":"2025-08-28 23:19","pubTimestamp":1756394342,"startTime":"0","endTime":"0","summary":"英诺特半年报数据显示，2025年1-6月营业总收入为2.76亿元，较去年同期下滑34.35%，净利润为1.25亿，较去年同期下滑39.36%，每股收益0.92元，净资产收益率为5.91%，每股经营现金流量为0.6264元，销售毛利率为80.40%，所处行业为生物制品。资料显示，英诺特成立于2006年，位于北京市丰台区海鹰路1号院6号楼1层2层，是一家以从事POCT快速诊断产品研发、生产和销售为主的企业。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/28231952789254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688253"],"gpt_icon":0},{"id":"2562581340","title":"英诺特：上半年净利润1.25亿元，同比下降39.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562581340","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562581340?lang=zh_cn&edition=full","pubTime":"2025-08-28 21:36","pubTimestamp":1756388218,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["688253","BK0239"],"gpt_icon":0},{"id":"2558835566","title":"医疗器械行业行业研究：脑机接口行业深度：政策+创新双轮驱动，商业化落地进入快车道","url":"https://stock-news.laohu8.com/highlight/detail?id=2558835566","media":"国金证券","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558835566?lang=zh_cn&edition=full","pubTime":"2025-08-10 12:06","pubTimestamp":1754798792,"startTime":"0","endTime":"0","summary":"投资逻辑国内政策叠加资本双重支持，行业迎来重大发展机遇。近年来国内政策端对脑机接口行业支持力度较高，支持性政策在产品注册、医保支付、行业标准等层面均有体现。1）在产品注册方面，国家药监局将配合相关部门出台基于脑机接口技术的医疗器械产品支持政策，脑机接口相关产品有望通过创新器械绿色通道实现更快注册审批。其中医疗健康领域仍是脑机接口应用最大的细分领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081012063594da7295&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081012063594da7295&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688050","688013","688151","688289","688068","688217","688410","603222","605369","688656","688212","688026","603987","560260","688298","688580","600807","688085","600055","688767","688075","688277","688271","688029","600645","688253","688581","688114","603014","688273","688317","688338","688613","688351","688301","688236","603880","688426","688139","603205","688389","600587","688393","688575","688607","688198","159883","688617","688755","688193","603658","600529","688366","688358","688468","688067","688314","603976","688576","688606","688016","688108","603387","603309","688677","688161"],"gpt_icon":0},{"id":"2557367037","title":"个股概念调整|英诺特新增“肝炎概念”概念","url":"https://stock-news.laohu8.com/highlight/detail?id=2557367037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557367037?lang=zh_cn&edition=full","pubTime":"2025-08-05 15:15","pubTimestamp":1754378133,"startTime":"0","endTime":"0","summary":"2025年08月05日，英诺特新增了肝炎概念概念。英诺特的所属概念，还有：融资融券、病毒检测、流感、猴痘、转融券标的、科创企业同股同权。个股概念调整既是市场认知的再校准，也是企业战略的显性化映射。对于投资者而言：①概念新增往往预示新业务增长点的价值重估窗口 ②概念移除需警惕业务收缩或市场预期修正风险 ③交叉验证财务数据与概念含金量是避免\"伪概念\"陷阱的关键 ④关注机构持仓变化与概念调整的协同性可捕捉主力动向。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805151537a6d3ed43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805151537a6d3ed43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688253","BK0239"],"gpt_icon":0},{"id":"2556742168","title":"猴痘概念盘中跳水，义翘神州跌1.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556742168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556742168?lang=zh_cn&edition=full","pubTime":"2025-08-04 09:46","pubTimestamp":1754271983,"startTime":"0","endTime":"0","summary":"08月04日，猴痘概念盘中跳水，截至09点46分，猴痘概念整体指数下跌1.05%，报1112.230点。从个股上来看，该概念的成分股中，义翘神州跌1.06%，英诺特、博拓生物、新产业跌幅居前。从资金上来看，截止发稿，猴痘概念主力净流入为-1.64亿，其中海辰药业受到资金热捧，主力净流入5742.39万；拉长时间线来看，该板块近20日主力资金净流入-35.63亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804094623a6d138c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804094623a6d138c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767","688253","301047","BK0239","BK0216"],"gpt_icon":0},{"id":"2555046932","title":"英诺特中标乐山市人民医院试剂项目 券商看好买入评级提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2555046932","media":"自选股中标信息","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555046932?lang=zh_cn&edition=full","pubTime":"2025-07-30 19:15","pubTimestamp":1753874157,"startTime":"0","endTime":"0","summary":"2025年07月30日，据天眼查数据，乐山市市中区人民医院2025年检验科挂网试剂公开院内遴选结果公告显示，中标方为英诺特，招标方为乐山市市中区人民医院。近半年内，英诺特获得1家券商积极评价：国投证券给予\"买入\"评级。英诺特主营业务涵盖呼吸道系列，其他试剂系列，优生优育系列，POCT诊断仪器。截至发稿，英诺特股价报32.29元，下跌0.19%，成交额至9764.59万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730191601a46b7fff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730191601a46b7fff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688253"],"gpt_icon":0},{"id":"2554714742","title":"每周股票复盘：英诺特（688253）完成7801.24万元股份回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2554714742","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554714742?lang=zh_cn&edition=full","pubTime":"2025-07-27 06:28","pubTimestamp":1753568895,"startTime":"0","endTime":"0","summary":"截至2025年7月25日收盘，英诺特报收于32.85元，较上周的31.55元上涨4.12%。本周，英诺特7月25日盘中最高价报33.35元。英诺特当前最新总市值44.83亿元，在医疗器械板块市值排名80/126，在两市A股市值排名3449/5148。本周关注点公司公告汇总：英诺特完成7801.24万元股份回购，回购股数2112740股，占总股本1.5483%公司公告汇总英诺特完成了股份回购计划，回购金额总计7801.24万元，回购股数2112740股，占总股本1.5483%，回购价格区间为28.62元至45.37元每股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072700001179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"gpt_icon":0},{"id":"2554769021","title":"英诺特：累计回购约211万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2554769021","media":"每日经济新闻","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554769021?lang=zh_cn&edition=full","pubTime":"2025-07-25 18:32","pubTimestamp":1753439530,"startTime":"0","endTime":"0","summary":"每经AI快讯，英诺特7月25日晚间发布公告称，截至本公告披露日，公司本次股份回购计划实施完毕。公司通过上海证券交易所交易系统以集中竞价交易方式累计回购公司股份约211万股，占公司总股本约1.36亿股的比例为1.5483%，回购成交的最高价为45.37元/股，最低价为28.62元/股，支付的资金总额为人民币约7801万元。每经头条（nbdtoutiao）——马斯克转发，鸿蒙智行“不予置评”，懂车帝辅助驾驶测试“火”了！专家：当前的“智驾”均为辅助驾驶（记者 曾健辉）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725183301971e2566&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725183301971e2566&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688253"],"gpt_icon":0},{"id":"2552041702","title":"每周股票复盘：英诺特（688253）全资子公司获新资质拓宽产品种类","url":"https://stock-news.laohu8.com/highlight/detail?id=2552041702","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552041702?lang=zh_cn&edition=full","pubTime":"2025-07-20 05:54","pubTimestamp":1752962056,"startTime":"0","endTime":"0","summary":"截至2025年7月18日收盘，英诺特报收于31.55元，较上周的30.52元上涨3.37%。本周，英诺特7月18日盘中最高价报31.88元。此产品预期用于体外定性检测人粪便样本中诺如病毒GI型/GII型核酸。产品的实际销售受多种因素影响，利润贡献具有不确定性，无法预测对英诺特未来经营业绩的具体影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072000001421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"gpt_icon":0},{"id":"2552624468","title":"英诺特(688253.SH)子公司近期获得一项资质","url":"https://stock-news.laohu8.com/highlight/detail?id=2552624468","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552624468?lang=zh_cn&edition=full","pubTime":"2025-07-18 16:01","pubTimestamp":1752825719,"startTime":"0","endTime":"0","summary":"智通财经APP讯，英诺特(688253.SH)发布公告，公司全资子公司英诺特(唐山)生物技术有限公司(简称“唐山英诺特”)近期新取得产品资质1项，产品名称：诺如病毒GI型/GII型核酸检测试剂盒(PCR荧光探针法)。上述资质的取得，拓宽了公司产品的种类，进一步提高了公司的市场拓展能力及核心竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1319413.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688253","BK0239"],"gpt_icon":0},{"id":"2551662190","title":"多家跨国医疗巨头奔赴链博会，本土药械供应链再升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2551662190","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551662190?lang=zh_cn&edition=full","pubTime":"2025-07-16 00:15","pubTimestamp":1752596100,"startTime":"0","endTime":"0","summary":"第一财经记者获悉，即将于7月16日开幕的第三届中国国际供应链促进博览会，包括美敦力、阿斯利康、GE医疗等跨国医疗巨头确认参展。美敦力方面介绍，今年是该公司首次参加链博会，并将展示一款全新的由美敦力中国研发中心和本土临床专家合作的起搏心脏导管研发成果。在本届链博会上，阿斯利康国际市场供应链管理高级执行总裁Steven Rota也将发表主旨演讲。阿斯利康已连续第三年参加链博会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716062402a44d2312&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716062402a44d2312&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600645","688013","688114","688289","688253","688351","688410","688273","159891","688468","688026","603387","688317","688606","688677","688755","688050","688068","688217","BK0239","688067","603014","603976","688301","688581","688108","688338","600529","688626","688358","688399","688767","688426","603222","603880","688576","688271","688198","688575","688085","688075","688607","688656","688389","688139","688580","600055","688366","600587","605369","688029","688298","688314","603205","688161","688613","603301","688617","603658","603987","600807","688151","688193","688393","688016","688212","603309","688236"],"gpt_icon":0},{"id":"2551812919","title":"每周股票复盘：英诺特（688253）全资子公司获流感病毒抗原检测试剂盒长期资质","url":"https://stock-news.laohu8.com/highlight/detail?id=2551812919","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551812919?lang=zh_cn&edition=full","pubTime":"2025-07-13 03:22","pubTimestamp":1752348130,"startTime":"0","endTime":"0","summary":"截至2025年7月11日收盘，英诺特报收于30.52元，较上周的30.08元上涨1.46%。本周，英诺特7月10日盘中最高价报31.37元。本周关注点英诺特全资子公司获流感病毒抗原检测试剂盒长期资质公司公告汇总北京英诺特生物技术股份有限公司全资子公司英诺特（唐山）生物技术有限公司近期新取得一项产品资质，产品名称为Innovita Flu A/B Antigen Rapid Test，注册证号为K250398，发证日期为2025年7月3日，有效期为长期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071300000562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"gpt_icon":0},{"id":"2549538637","title":"英诺特：子公司新取得一项产品资质 有助于提高公司市场拓展能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2549538637","media":"中国财富通","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549538637?lang=zh_cn&edition=full","pubTime":"2025-07-07 17:40","pubTimestamp":1751881203,"startTime":"0","endTime":"0","summary":"7月7日，英诺特（688253）公告称，公司全资子公司英诺特（唐山）生物技术有限公司近期新取得产品资质1项，系美国 FDA 510（k）产品文号，产品名称为Innovita Flu A/B Antigen Rapid Test（甲型流感病毒/乙型流感病毒抗原检测试剂盒），上述资质的取得，拓宽了公司产品业务线的种类，进一步提高了公司的市场拓展能力及核心竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=It5w60IL8pM%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688253"],"gpt_icon":0},{"id":"2549324937","title":"英诺特最新公告：全资子公司唐山英诺特取得1项美国FDA510（k）产品文号","url":"https://stock-news.laohu8.com/highlight/detail?id=2549324937","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549324937?lang=zh_cn&edition=full","pubTime":"2025-07-06 16:09","pubTimestamp":1751789379,"startTime":"0","endTime":"0","summary":"英诺特(688253.SH)公告称，公司全资子公司唐山英诺特近期新取得1项美国FDA510（k）产品文号，为InnovitaFluA/BAntigenRapidTest（甲型流感病毒/乙型流感病毒抗原检测试剂盒）。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070600004226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"gpt_icon":0},{"id":"2549184324","title":"英诺特全资子公司唐山英诺特近期新取得产品资质1项","url":"https://stock-news.laohu8.com/highlight/detail?id=2549184324","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549184324?lang=zh_cn&edition=full","pubTime":"2025-07-06 15:45","pubTimestamp":1751787906,"startTime":"0","endTime":"0","summary":"格隆汇7月6日丨英诺特(688253.SH)公布，公司全资子公司英诺特(唐山)生物技术有限公司(以下简称\"唐山英诺特\")近期新取得产品资质1项，具体情况如下表所示：","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250706154519953841c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250706154519953841c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688253"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1758461509763,"stockEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":-0.0724},{"period":"3month","weight":0.0385},{"period":"6month","weight":-0.1459},{"period":"1year","weight":-0.1553},{"period":"ytd","weight":-0.1322}],"compareEarnings":[{"period":"1week","weight":-0.013},{"period":"1month","weight":0.0143},{"period":"3month","weight":0.137},{"period":"6month","weight":0.1353},{"period":"1year","weight":0.3962},{"period":"ytd","weight":0.1397}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京英诺特生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"7269人(较上一季度减少2.94%)","perCapita":"9466股","listingDate":"2022-07-28","address":"北京市丰台区海鹰路1号院6号楼1层2层","registeredCapital":"13645万元","survey":" 北京英诺特生物技术股份有限公司的主营业务是POCT快速诊断产品研发、生产和销售。公司的主要产品是呼吸道系列、优生优育系列、其他试剂系列、POCT诊断仪器。","listedPrice":26.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"英诺特(688253)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供英诺特(688253)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"英诺特,688253,英诺特股票,英诺特股票老虎,英诺特股票老虎国际,英诺特行情,英诺特股票行情,英诺特股价,英诺特股市,英诺特股票价格,英诺特股票交易,英诺特股票购买,英诺特股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"英诺特(688253)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供英诺特(688253)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}